Élan Corporation, plc

https://www.elan.com

Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing, selling and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. Elan's (NYSE: ELN) shares trade on the New York, London and Dublin Stock Exchanges. *

	Start	1998-08-26 existent
	End	acquired
	Group	Élan (Group)
	Today	Perrigo Company plc
	Successor	Perrigo Company plc
	Industry	pharmaceutical

	Region	Dublin
	Country	Ireland, Republic of
	Street	Lower Grand Canal Street, Treasury Building
	City	n. a. Dublin 2
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	759,400,000 (revenue, total, consolidated (2007) 2007-12-31)
	Profit	-405,000,000 (2007-12-31)
	Cash	423,500,000 (2007-12-31)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)